Sutter Health Adopts Wearable Ultrasound to Optimize Sepsis Care
July 23, 2025
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets
Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine.
https://www.discovermagazine.com/health/how-a-chatty-ancient-protein-in-our-gut-could-be-giving-us-a-sixth-sense
Philips (NYSE: PHG)+ announced today that it received FDA 510(k) clearance for the latest UroNav image-guided navigation system.
Elekta announced today that it received FDA 510(k) clearance to expand indications for its Leksell Gamma Knife radiosurgery system.
Imperative Care announced today that it received FDA 510(k) clearance for its novel Zoom 7X catheter for aspiration thrombectomy procedures.
A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non-invasive cancer treatments.
A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer’s disease treatments: Intranasal insulin, delivered via a simple nasal spray, safely and effectively reaches key memory regions of the brain in older adults. The study also revealed that people with early cognitive decline absorb it differently.
Although lithium is highly effective in treating bipolar disorder, the chemical has a narrow therapeutic window—too high a dose can be toxic to patients, causing kidney damage, thyroid damage, or even death, while too low a dose renders the treatment ineffective.